ConclusionThis

Related by string. * * *

Related by context. Frequent words. (Click for all words.) 68 Observational studies 66 subgroup analyzes 64 nonrandomized 64 epidemiologic studies 63 genetic determinants 62 immunohistochemical 61 genetic polymorphisms 61 histopathological 60 thyroid nodules 60 pharmacodynamic effects 60 randomized controlled clinical trials 60 placebo controlled trials 60 microRNA expression 60 histopathologic 60 meta analyzes 60 correlational 59 Computed tomography 59 biopsychosocial 59 placebo controlled studies 59 Epidemiological studies 59 etiologic 58 subanalysis 58 prognostic markers 58 neuropsychiatric symptoms 58 neuroimaging studies 58 randomized trials 58 metabolic parameters 58 teriflunomide 58 Azedra 58 enzastaurin 58 vitro experiments 58 tumor biopsies 57 renal tumors 57 substudy 57 prognostic marker 57 Randomized controlled 57 placebo controlled clinical 57 elevated CRP 57 pharmacokinetic PK 57 silymarin 57 Neuradiab 57 prospective multicenter 57 randomized controlled trials 57 retrospective cohort study 57 Radiographs 57 double blinded placebo 57 superficial bladder cancer 57 eprotirome 57 liver transplant recipients 57 EoE 57 malignant pleural mesothelioma 57 RCTs 57 secretin 57 prognostic indicator 57 serologic 57 atherothrombosis 57 dietary interventions 57 lipid lowering agents 56 Golimumab 56 meta analysis 56 multicentre 56 serum lipids 56 prospective observational 56 recurrent miscarriage 56 prognostic significance 56 adenotonsillectomy 56 body fatness 56 liver biopsies 56 methylation patterns 56 logistic regression analysis 56 cytological 56 pharmacological interventions 56 optimal dosing 56 observational studies 56 rheumatic diseases 56 randomized clinical 56 Chlamydia pneumoniae 56 pharmacokinetic parameters 56 Metallurgical testwork 56 CR# vcMMAE 56 prospectively defined 56 gut microbiota 56 pharmacokinetics PK 56 GFT# 56 studies GWAS 56 zinc supplementation 56 generalizability 55 dietary intakes 55 placebo controlled clinical trials 55 PLX cells 55 molecular biomarkers 55 tigecycline 55 randomized Phase III 55 sentinel lymph node biopsy 55 Baseline characteristics 55 calcium supplementation 55 MERLIN TIMI 55 CALGB 55 atherosclerotic lesions 55 epidemiological studies 55 cardiovascular morbidity

Back to home page